Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Silvia Buratti is active.

Publication


Featured researches published by Silvia Buratti.


Journal of Pediatric Gastroenterology and Nutrition | 2004

Granular cell tumor of the esophagus: report of a pediatric case and literature review.

Silvia Buratti; Thomas J. Savides; Robert O. Newbury; Ranjan Dohil

Granular cell tumors (GCT) are submucosal or subcutaneous tumors most commonly found in skin, tongue, and breast. Tumors involving the gastrointestinal tract account for 8% of all GCT (1), and only 2% are found in the esophagus (2,3). In 1926, Abrikossoff reported the first five cases of GCT of the tongue, designating them as “myoblastomas,” and in 1931 he reported the first GCT of the esophagus (4). By 1998, approximately 270 cases of GCT of the esophagus had been reported. Esophageal GCT are more common in women and black patients, and most occur in the fourth, fifth, and sixth decade (5–7). To our knowledge no cases of GCT of the esophagus have been reported in children. We report the first GCT of the esophagus in a pediatric patient and review the literature concerning clinicopathologic aspects and management of these uncommon tumors.


Current Opinion in Pediatrics | 2002

Drugs and the liver: advances in metabolism, toxicity, and therapeutics.

Silvia Buratti; Joel E. Lavine

Biotransformation of drugs is one of the major functions of liver. Hepatic drug metabolism develops early in organogenesis and continues in postnatal life through puberty. Genetic and developmental studies on hepatic drug metabolism show that immaturity, polymorphisms, and altered balance of different hepatic enzymatic activities affect pharmacologic inactivation and alter the risk of toxic effects of drugs on the hepatic parenchyma. Although drug-induced liver disease is less common in children, several reports of hepatotoxicity are published every year. Furthermore, the increasing use of nonregulated remedies (eg, herbal preparations or recreational drugs) increases the risk of unpredictable and potentially severe reactions. Many significant advances in the treatment of hepatic diseases have been achieved recently. However, differences in clinical features, natural history, and response to treatment between children and adults require evaluation of new therapeutic options in focused pediatric clinical trials.


Pediatrics | 2015

Severe Neonatal Legionella Pneumonia: Full Recovery After Extracorporeal Life Support.

Andrea Moscatelli; Silvia Buratti; Elio Castagnola; Alessio Mesini; Pietro Tuo

Legionella pneumophila is responsible for hospital or community-acquired pneumonia. Neonatal legionellosis is associated with rapidly severe clinical course and high mortality rates. We describe a case of hospital-acquired Legionella pneumonia in a newborn with undiagnosed tracheoesophageal fistula and acute respiratory failure requiring venovenous extracorporeal membrane oxygenation support before fistula repair. Standardized multiplex polymerase chain reaction assay allowed early diagnosis. Extracorporeal life support associated with appropriate antibiotic therapy, surfactant, and steroid therapy was effective in achieving complete recovery. This is the first report of successful neonatal extracorporeal life support for respiratory failure secondary to L pneumophila.


International Journal of Artificial Organs | 2015

Emergency percutaneous, bicaval double-lumen, ECMO cannulation in neonates and infants: Insights from three consecutive cases

Andrea Moscatelli; Silvia Buratti; Cesare Gregoretti; Elisabetta Lampugnani; Pietro Salvati; Maurizio Marasini; Elena Ribera; Ezio Fulcheri; Pietro Tuo

Background Veno-venous extracorporeal membrane oxygenation (ECMO) is probably the preferable configuration to assist children with respiratory failure who do not respond to maximized conventional therapies. The single-vessel, double-lumen approach through the internal jugular vein is extremely advantageous, especially in infants, where femoral access presents limitations related to the small dimensions of the veins. In case of emergencies, ECMO might need to be started at the bedside, without the availability of fluoroscopic guidance. To our knowledge, a completely percutaneous approach has not been reported before in children younger than 1 year and weighing less than 5 kg. Methods We describe 3 cases of emergency bedside, percutaneous, bicaval double-lumen cannulation under real-time transthoracic ultrasound control in 2 neonates and 1 infant. Results In our experience, this approach proved to be safe, effective and time saving, while minimizing bleeding from the cannula insertion site. Cannulation times, from decision making to the beginning of ECMO flow, were 30, 28, 25 minutes respectively, from patient 1 to 3. We do not report any cannula-related injury to vessels and heart structures. Conclusions Our preliminary data suggest that, with the described precautions, percutaneous, echo-guided, bicaval double-lumen cannulation in neonates and infants could be effective and free from major complications. Further evaluation should be warranted in the neonatal population.


Pediatrics | 2016

Venovenous ECMO for congenital diaphragmatic hernia: Role of ductal patency and lung recruitment

Andrea Moscatelli; Stefano Pezzato; Gianluca Lista; Lara Petrucci; Silvia Buratti; Elio Castagnola; Pietro Tuo

We report a case of antenatally diagnosed left-sided congenital diaphragmatic hernia, managed on venovenous extracorporeal membrane oxygenation with an hemodynamic and ventilation strategy aimed at preventing left and right ventricular dysfunction. Keeping the ductus arteriosus open with prostaglandin infusion and optimizing lung recruitment were effective in achieving hemodynamic stabilization and an ideal systemic oxygen delivery. The patient was discharged from the hospital and had normal development at 1 year of age. The combination of ductal patency and lung recruitment has not been previously reported as a strategy to stabilize congenital diaphragmatic hernia patients undergoing venovenous extracorporeal membrane oxygenation. We believe that this approach may deserve further evaluation in prospective studies.


Journal of Perinatology | 2012

Congenital diaphragmatic hernia repair during whole body hypothermia for neonatal hypoxic ischemic encephalopathy.

Silvia Buratti; Elisabetta Lampugnani; Pietro Tuo; Andrea Moscatelli

Major malformations, surgery and persistent pulmonary hypertension (PHT) have been considered contraindications to therapeutic hypothermia (TH) in newborns with hypoxic-ischemic encephalopathy (HIE). We report two patients with undiagnosed congenital diaphragmatic hernia (CDH) who developed HIE after birth. Diagnosis of moderate HIE was formulated based on clinical, laboratory and electroencephalographic criteria. The patients were treated with whole body hypothermia (33.5 °C) for 72 h. During hypothermia the patients underwent surgical repair with regular perioperative course. Ventilatory support with high-frequency oscillatory ventilation, oxygen requirements and inotropic support remained stable during hypothermia. Serial echocardiographic evaluations did not demonstrate any change in pulmonary pressure values. In our experience TH did not increase the risk of hemodynamic instability, PHT or bleeding. Hypothermia may be considered in patients with HIE and CDH or other surgical conditions with favorable prognosis.


The Journal of Rheumatology | 2001

Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.

Silvia Buratti; Ilona S. Szer; Charles H. Spencer; Sharon Bartosh; Andreas Reiff


The Journal of Rheumatology | 2001

Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Angelo Ravelli; Maria Cristina Caria; Silvia Buratti; Clara Malattia; Francesca Temporini; Alberto Martini


Pediatric Surgery International | 2004

Esophagogastric disconnection following failed fundoplication for the treatment of gastroesophageal reflux disease (GERD) in children with severe neurological impairment

Silvia Buratti; Rose Kamenwa; Ranjan Dohil; David L. Collins; Joel E. Lavine


Pediatrics | 2005

Chapter 81 – Approach to the Child with Abdominal Pain

Jeffrey Schwimmer; Silvia Buratti

Collaboration


Dive into the Silvia Buratti's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pietro Tuo

Istituto Giannina Gaslini

View shared research outputs
Top Co-Authors

Avatar

Ranjan Dohil

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alberto Martini

Istituto Giannina Gaslini

View shared research outputs
Top Co-Authors

Avatar

Clara Malattia

Istituto Giannina Gaslini

View shared research outputs
Top Co-Authors

Avatar

Elio Castagnola

Istituto Giannina Gaslini

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andreas Reiff

Children's Hospital Los Angeles

View shared research outputs
Researchain Logo
Decentralizing Knowledge